- Home
- ASST vs NKTR Comparison
ASST vs NKTR Comparison
Compare ASST & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASST | NKTR |
|---|---|---|
| Founded | 2020 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 913.3M | 1.1B |
| IPO Year | 2023 | 1994 |
Fundamental Metrics
Financial Performance| Metric | ASST | NKTR |
|---|---|---|
| Price | $1.03 | $56.80 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $106.33 |
| AVG Volume (30 Days) | ★ 115.4M | 669.8K |
| Earning Date | 11-14-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $5,512,106.00 | ★ $62,600,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 125.01 | N/A |
| 52 Week Low | $0.78 | $6.48 |
| 52 Week High | $7.89 | $66.92 |
Technical Indicators
Market Signals| Indicator | ASST | NKTR |
|---|---|---|
| Relative Strength Index (RSI) | 39.02 | 48.10 |
| Support Level | $1.00 | $53.29 |
| Resistance Level | $1.12 | $66.86 |
| Average True Range (ATR) | 0.11 | 4.23 |
| MACD | 0.04 | -0.19 |
| Stochastic Oscillator | 24.78 | 32.03 |
Price Performance
Historical ComparisonAbout ASST Asset Entities Inc. Class B
Strive Inc is engaged in providing investment advisory, wealth management, and consulting services through its subsidiary. Its objectives is to (i) accumulate Bitcoin; (ii) increase Bitcoin-per-share; and (iii) outperform Bitcoin over the long run by deploying both beta Bitcoin treasury accumulation strategies and alpha investment strategies with the goal of beating Bitcoin's investment performance as the hurdle rate.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.